Ketamine-assisted psychotherapy is sometimes misunderstood as ketamine treatment with therapy added around it. At Acheron Psychiatry, we understand it differently. When the medicine creates an opening, the therapeutic frame determines how that opening is prepared for, held, understood, and integrated.
What Ketamine-Assisted Psychotherapy Means
Ketamine-assisted psychotherapy, or KAP, is a clinical approach that combines medically supervised ketamine administration with psychotherapy. Ketamine is a medication originally developed as an anesthetic. In KAP, it is used within a mental health treatment frame that includes preparation, supervision, and integration.
At Acheron Psychiatry, KAP is not treated as a procedure that happens to include conversation. It is part of a broader depth-oriented model of care. That means we are interested not only in symptom relief, but in what may become visible when a patient has enough safety, support, and flexibility to examine familiar defenses, repetitions, or self-protective patterns.
A patient may enter KAP hoping to feel less depressed, less anxious, less stuck, or less constrained by trauma. Those goals matter. But in a therapeutic frame, we are also asking what the symptoms have been carrying, what the person has had to protect, and what kind of meaning can emerge when there is enough clinical safety to look more closely.
Why Ketamine Alone Is Not the Point
Ketamine can produce changes in perception, bodily awareness, emotion, and the relationship to thoughts or memories. In some cases, that shift may create a pause in the usual pattern. A person may feel less identified with a familiar inner voice, less trapped inside a loop, or more able to see a painful dynamic from a new angle.
But an opening is not the same as integration. A powerful experience does not automatically become psychological change. It has to be held, examined, and brought back into the patient’s ordinary life. Without a therapeutic frame, insight may fade, feel confusing, or remain disconnected from the relationships, decisions, symptoms, and patterns that brought the person to treatment.
Research on ketamine-assisted psychotherapy is still developing, with reviews emphasizing both potential clinical value and the need for more standardized study on how ketamine and psychotherapy should be integrated (Drozdz et al., 2022; Kew et al., 2023). That caution matters. We do not present KAP as a guaranteed breakthrough or as a treatment that works the same way for everyone.
At Acheron Psychiatry, the therapy frame matters because the medicine is not the whole treatment. The question is not only what happens during the ketamine session. It is what the patient brings into the session, what emerges there, and what can be understood afterward.
Preparation Is Clinical Work
Preparation is not just paperwork or logistics. It is part of the therapy. Before a ketamine medicine session, preparation may involve clarifying the patient’s history, current symptoms, fears, expectations, relationship to control, and emotional readiness.
For some patients, the fear is that nothing will happen. For others, the fear is that too much will happen. Some worry they will lose control, encounter painful material, or feel exposed in a way they cannot manage. These concerns are not obstacles to rush past. They are clinically meaningful. They may reveal the very patterns that treatment needs to respect.
In a depth-oriented frame, preparation asks what the patient is bringing into the ketamine session. Is there a wish to disappear? A hope for rescue? A longing to finally be fixed? A fear of dependence? A deep exhaustion with being defended all the time? KAP becomes more clinically meaningful when these questions are part of the work before the medicine is administered.
Integration Is Where Meaning Becomes Usable
Integration is the process of making sense of what occurs during and around the ketamine experience. Integration means connecting the material that emerges in treatment to the patient’s emotional life, relationships, symptoms, choices, and ongoing therapy.
A ketamine session may bring forward images, memories, bodily sensations, grief, relief, confusion, or unexpected perspective. The therapeutic task is not to assign quick meaning to everything that appears. It is to help the patient stay curious, grounded, and honest about what may have become available.
Sometimes integration is about insight. Sometimes it is about mourning. Sometimes it is about recognizing a defense that once protected the person but now keeps them isolated. Sometimes it is about allowing an experience of softness, anger, need, or aliveness that has been difficult to access in ordinary consciousness.
Studies of possible mechanisms in KAP have discussed neurobiological effects, shifts in mindset, psychotherapy, and other factors that may contribute to treatment outcomes, while also emphasizing that the evidence base remains limited and needs further research (Joneborg et al., 2022). This is why integration should not be treated as an optional add-on. It is the part of treatment that helps the experience become part of the person’s ongoing clinical work.
What KAP Looks Like at Acheron Psychiatry
At Acheron Psychiatry, individual KAP is offered through a Foundational Series that includes preparation, medically supervised ketamine medicine sessions, and integration. Ketamine sessions are conducted in office under medical supervision. Depending on the clinical plan, ketamine may be administered through an oral sublingual lozenge or intramuscular injection.
We also offer group-based ketamine-assisted psychotherapy options for appropriate patients. Group KAP is not simply a lower-intensity version of individual treatment. For some patients, the relational field of the group may become part of the therapeutic work: noticing what it feels like to be witnessed, defended, private, open, separate, or connected in the presence of others.
KAP may be considered for some adults experiencing depression, PTSD, anxiety, or bipolar disorder, but only after careful clinical evaluation, including attention to mood stability, medical history, psychiatric history, current safety considerations, and treatment goals. It is not right for every patient.
Off-Label Use, Safety, and Clinical Judgment
Racemic ketamine, as used in ketamine-assisted psychotherapy, is not FDA-approved to treat depression, PTSD, anxiety, bipolar disorder, or other psychiatric conditions. KAP for psychiatric conditions is an off-label use of ketamine. Off-label treatment decisions should be made carefully and only under the supervision of qualified medical providers.
Clinical caution is not a lack of belief in the work but instead a fundamental element of the work. Ketamine can involve dissociation, changes in perception, emotional intensity, blood pressure changes, nausea, sedation, or other effects that require appropriate screening and monitoring. Published discussions of ketamine’s off-label psychiatric use emphasize the importance of patient selection, safety procedures, monitoring, and informed clinical judgment (Wilkinson & Sanacora, 2017).
At Acheron Psychiatry, KAP is never treated as a shortcut around evaluation. A patient’s history matters. Their supports matter. Their expectations matter. Their relationship to control, dependency, medication, trauma, and the body may all matter. Results vary by individual, and a thoughtful evaluation helps determine whether KAP is appropriate or whether another form of care would be a better fit.
Cost, Scheduling, and Fear of the Experience
For many people, interest in KAP is mixed with hesitation. Some patients are drawn to the possibility of a different kind of treatment but feel nervous about changes in perception, medical supervision, cost, scheduling, or whether the experience will feel too intense.
Those concerns deserve direct attention. KAP is not something patients should feel rushed into because it sounds new, intensive, or different from prior treatment. It is something to explore carefully with a provider who can explain the treatment frame, review risks and alternatives, and help determine whether it fits the patient’s clinical needs.
Because costs and coverage may vary by service and treatment plan, we encourage patients to discuss financial questions with our care coordination team before beginning. Acheron Psychiatry is in-network with Aetna and Cigna for eligible services. For out-of-network patients, we provide superbills, and some patients may receive partial reimbursement once their deductible is met. HSA and FSA funds are accepted, and limited sliding scale availability may be considered case by case.
Scheduling is also part of clinical fit. KAP requires time for preparation, the medicine session itself, and integration afterward. Patients can begin with a complimentary phone consultation to explore their options, ask practical questions, and discuss whether a KAP evaluation may be an appropriate next step.
KAP Within a Wider Depth-Oriented Model
KAP is one part of Acheron Psychiatry’s broader clinical model, not the center of the practice. Our broader model includes psychotherapy, psychiatry, medication management, group work, trauma-focused care, neuropsychological assessment, and cognitive remediation when clinically appropriate.
The point is not to collect modalities. The point is to understand the person. Some patients need stabilization before depth work. Some need medication management to make therapy more possible. Some need trauma processing, relational work, cognitive support, or a treatment frame that can hold more than one layer of difficulty at a time.
Ketamine may create an opening for some patients. Therapy asks what the opening means. Integration asks how that meaning can be lived. For Acheron Psychiatry, that is the difference between a medicine session and ketamine-assisted psychotherapy.
Frequently Asked Questions
What is ketamine-assisted psychotherapy?
Ketamine-assisted psychotherapy, or KAP, combines medically supervised ketamine administration with psychotherapy, preparation, and integration. The therapy frame is central because the goal is not only to have an experience, but to understand what emerges and how it connects to the patient’s broader clinical work.
Is KAP the same as ketamine treatment?
Not exactly. Ketamine treatment may refer broadly to medically supervised ketamine administration. KAP specifically places ketamine inside a psychotherapeutic process that includes preparation before the session and integration afterward.
What happens during KAP preparation and integration?
Preparation helps clarify the patient’s history, goals, concerns, expectations, and readiness before the ketamine session. Integration helps the patient make meaning from what emerged and connect it to symptoms, relationships, emotions, defenses, and ongoing therapy.
Who may be a candidate for KAP?
KAP may be considered for some adults experiencing depression, PTSD, anxiety, or bipolar disorder when clinically appropriate. It is not right for every patient, and evaluation should include medical history, psychiatric history, mood stability, safety considerations, medication use, and treatment goals.
Does Acheron Psychiatry offer group KAP?
Yes. Acheron Psychiatry offers group-based ketamine-assisted psychotherapy options for appropriate patients. Group KAP includes a relational dimension that may be clinically meaningful for some people, though individual fit should be discussed with a provider.
Key Takeaways
- Ketamine-assisted psychotherapy is not ketamine alone. KAP places ketamine inside a therapeutic frame that includes preparation, supervision, and integration.
- When the medicine creates an opening, therapy gives that opening context. Integration helps connect the experience to the patient’s symptoms, relationships, defenses, and daily life.
- KAP research is clinically meaningful but still developing. Current reviews support cautious, grounded language rather than guaranteed claims.
- KAP for psychiatric conditions is an off-label use of racemic ketamine. It is not FDA-approved to treat depression, PTSD, anxiety, bipolar disorder, or other psychiatric conditions.
- Results vary by individual. Patients should discuss KAP, alternatives, risks, and clinical fit with a qualified provider.
Conclusion
Ketamine-assisted psychotherapy begins with the recognition that a medicine session is not the same as treatment. What matters is the frame: how the experience is prepared for, held, interpreted, and integrated into the patient’s ongoing life. At Acheron Psychiatry, we offer complimentary phone consultations to help you explore your options and discuss whether KAP may be an appropriate next step.
References
Drozdz, S. J., Goel, A., McGarr, M. W., Katz, J., Ritvo, P., Mattina, G. F., Bhat, V., Diep, C., & Ladha, K. S. (2022). Ketamine assisted psychotherapy: A systematic narrative review of the literature. Journal of Pain Research, 15, 1691–1706. https://pmc.ncbi.nlm.nih.gov/articles/PMC9207256/
Joneborg, I., Lee, Y., Di Vincenzo, J. D., Ceban, F., Meshkat, S., Lui, L. M. W., Fancy, F., Rosenblat, J. D., & McIntyre, R. S. (2022). Active mechanisms of ketamine-assisted psychotherapy: A systematic review. Journal of Affective Disorders, 315, 105–112. https://pubmed.ncbi.nlm.nih.gov/35905796/
Kew, B. M., Porter, R. J., Douglas, K. M., Glue, P., Mentzel, C. L., & Beaglehole, B. (2023). Ketamine and psychotherapy for the treatment of psychiatric disorders: Systematic review. BJPsych Open, 9(3), e79. https://pmc.ncbi.nlm.nih.gov/articles/PMC10228275/
Wilkinson, S. T., & Sanacora, G. (2017). Considerations on the off-label use of ketamine as a treatment for mood disorders. JAMA, 318(9), 793–794. https://pubmed.ncbi.nlm.nih.gov/28806440/
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine-assisted psychotherapy, ketamine-assisted treatment, psychotherapy, medication management, and other mental health treatments should only be considered with guidance from a qualified provider who has reviewed your full medical and psychiatric history. Ketamine-assisted psychotherapy for psychiatric conditions is an off-label use of racemic ketamine, and racemic ketamine is not FDA-approved to treat depression, PTSD, anxiety, bipolar disorder, or other psychiatric conditions. Individual results vary. If you are experiencing a mental health crisis, thoughts of self-harm, or thoughts of suicide, call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.
